Oestrogen replacement therapy has been shown to protect postmenopausal women from ischaemic heart disease, strokes and hypertension. 
Introduction
In postmenopausal women, oestrogen has been shown to exert a cardioprotective effect independent of age, cigarette smoking, or the presence of diabetes mellitus, hypertension, hypercholesterolaemia or obesity (Sullivan et al. 1988) . One of the ways in which oestrogen may exert its cardioprotective effect is by influencing the levels and metabolism of fatty acids. For example, the produc¬ tion of prostacychn, an inhibitor of platelet aggregation and a potent vasodilator, has been shown to be signifi¬ cantly decreased in uterine arteries in postmenopausal women (Steinleitner et al. 1989 ). Since prostacychn is a derivative of arachidonic acid, it is possible that oestrogens may affect prostacychn production via an effect on arachidonic acid metabolism. Arachidonic acid metab¬ olism, especially in platelet membranes, has been shown to be important in coronary artery disease (Wood et al. 1987 ).
There is little information about the effect of oestrogen on platelet membrane fatty acid composition; this study was undertaken to examine the possibility that changes may be present in postmenopausal women and that these may be reversible with oestrogen treatment.
Materials and Methods

Subjects
Thirty one women were recruited and consented to the study which had been approved by the Ethical Committee at Epsom General Hospital. All subjects had stopped menstruating for at least three months and/or had symp¬ toms of the menopause. All had elevated levels of serum luteinizing hormone (LH; >25 iu/1), follicle-stimulating hormone (FSH; >25 iu/1) and virtually undetectable 17ß-oestradiol (<0T nmol/1). None of the subjects was on any form of hormone replacement therapy (HRT) at the time of recruitment. No subject had any known major health problems except for one subject with diabetes requiring insulin therapy; five subjects were smokers and twenty-six subjects were non-smokers. Alcohol con¬ sumption between 10-14 units, 5-9 units and <5 units per week was noted in 7, 2 and 22 subjects respectively. Subjects were counselled to adhere to alcohol and smoking habits similar to those levels declared prior to initiation of HRT Analysis ofplatelet membrane fatty acids The membrane-bound fatty acids were simultaneously hydrolysed and re-esterified to methyl esters using the anhydrous alkaline methanolysis derivatisation procedure. The free fatty acid methyl esters together with internal standard (C 17:0) were extracted into n-hexane at neutral pH. The extracts were dried under nitrogen, reconstituted in methanol/toluene and analysed by capillary gas-liquid chromatography using a 30 metre DB 225 column as described previously (Barradas et al. 1990 ). Identification of fatty acids was achieved by direct injection of authen¬ ticated fatty acid methyl esters as well as free fatty acid standards. The sum of all fatty acid peaks between the relative retention times defined by C 16:0 and C 22:6 (which included all the fatty acids discussed in this study) was considered to be 100%. Individual fatty acid peaks were quantitated as a percentage of this total. The sensi¬ tivity of the analysis was adjusted such that fatty acids with relative proportions greater than 0-12% of the total were included in the quantitation. The fatty acids that achieved quantitation accounted for 95-98% of the total (including C 17:0, an internal standard, the relative concentration of which was <5 %). The within-batch CV for palmitic, stearic, oleic, linoleic, di-homo-y-linoleic (DGLA) and arachidonic (AA) acids were 3-7, 1-7, 1-7, 2-6, 4-6 and 1-2% respectively. The pre-and Polyunsaturated fatty acids (PUFA) As a proportion of total membrane lipids, the relative levels of all PUFA in platelet membranes decreased significantly after 6 weeks of HRT. This included both n3 PUFA and n6 PUFA (P<0-003 for all). For arachidonic acid, this represented a decrease from 22-7 to 18-6% of total lipids after HRT, a relative change of 17-8%, and for linoleic acid a decrease from 6-1 to 5-6%, a relative change of 8-1% (Fig. la) .
The total saturated fatty acid content of membranes increased from 37-4% to 40-8% following HRT, while total MUFA content increased from 20-2% to 21-6% (PO-001 for each).
The sum of n6 PUFA and of n3 PUFA both showed a marked fall after six weeks of HRT from 32-3 to 27-4% and from 3-7 to 2-7% respectively ( <0 01 for both). There was no correlation between any of the changes in serum lipoproteins and membrane fatty acids (Table 2 ).
Discussion
The proportions of palmitic, stearic, oleic, linoleic and arachidonic fatty acids in platelet membranes were similar to those described by previous workers (Wood et al. 1987 , Kinsella 1990 ). The main findings of this study indicate a change in platelet membrane fatty acid composition in response to HRT treatment, with an overall increase in the proportion of saturated and mono-unsaturated fatty acids (+9-1 and +7-1% respectively) and a decrease in the proportion of n3, n6 and total polyunsaturated fatty acids (-27%, -15% and -16-2% respectively). From a physiologi¬ cal point of view, we believe that the most important platelet membrane fatty acid change was the observed reduction in arachidonic acid and the possible significance of this change is discussed later. The change in the relative proportions of the fatty acids suggests decreases in the activities of both -4-and -5-desaturase activities.
It is unlikely that the changes observed were due to day-to-day fluctuations in diet and life-style; subjects were encouraged to maintain the same life-style (including diet, smoking and alcohol consumption) between the platelet membrane measurements. In addition, previous studies have shown very little day-to-day fluctuation in platelet membrane fatty acid composition (Mori et al. 1987) .
The changes in PUFA of the n3 and n6 series (with the exception of linoleic acid) could be due to (i) decreased desaturation and/or chain elongation (Kinsella 1990), (ii) (Sanders 1983) . It has been postulated that an increase in platelet arachidonic acid may predispose to a number of disease processes by enhancing the generation of eicosanoids and other mediators of tissue injury (Kinsella 1990 ). Thus, the observed decrease in platelet arachidonic acid content in response to HRT may be a beneficial change.
